相关实验视频

Updated: Jun 15, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

一个布莱顿协作标准化模板,其中包含对科米纳蒂COVID-19 mRNA疫苗的益处风险评估的关键考虑因素

Shanti Pather¹, Nicola Charpentier¹, Frank van den Ouweland¹

¹BioNTech SE, Mainz, Germany.

|August 28, 2024

概括

布莱顿协作技术对疫苗的利益风险评估 (BRAVATO) 工作组评估了mRNA COVID-19疫苗. 利益风险评估证实了BNT162b2及其变种适应版本的安全性和有效性.

科学领域:

疫苗学疫苗学疫苗学
免疫学免疫学免疫学
公共卫生公共卫生

背景情况:

新的疫苗技术,如mRNA平台,需要严格的利益风险评估.
布莱顿协作技术对疫苗的利益风险评估 (BRAVATO) 工作组为评估新疫苗提供了一个框架.
由于COVID-19的流行,疫苗的快速开发和部署成为必要,其中包括基于mRNA的疫苗.

研究的目的:

应用 BRAVATO 模板来评估 Pfizer-BioNTech COVID-19 mRNA 疫苗 (BNT162b2) 和其适应变异的配方的益处风险概况.
评估BNT162b2及其更新版本对SARS-CoV-2变种的安全性,免疫性和疗效.
审查实际证据和临床试验数据,以支持利益风险评估.

主要方法:

使用BRAVATO框架进行结构化利益风险评估.
对BNT162b2和适应变种的疫苗的安全性,免疫性和疗效的临床试验数据进行了审查.
整合了现实世界的证据,以支持持续评估疫苗的益处和风险.

主要成果:

对于BNT162b2的初始紧急使用授权是基于有利的利益风险评估.
随后的数据证实了年轻年龄组的有利利益风险概况,并通过现实世界的证据.
针对SARS-CoV-2变种的双等效疫苗也显示了维持有利的利益风险平衡.

结论:

BNT162b2 mRNA疫苗及其变异适应版本显示了有利的COVID-19预防的益处风险概况.
持续的监测和数据积累支持持续评估疫苗对不断演变的病毒株的益处.
布拉瓦托框架是评估新型疫苗技术及其对公共卫生影响的宝贵工具.

关键词:

BNT162b2b2 在线阅读这是COVID-19疫苗.新冠病毒新冠病毒新冠病毒.这就是SARS-CoV-2病毒.疫苗的益处/风险对比.疫苗安全性疫苗安全性

更多相关视频

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

相关概念视频

Hazard Ratio

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...